Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Does a calculated "NAFLD fibrosis score" reliably negate the need for liver biopsy in patients undergoing bariatric surgery?

Simo KA, McKillop IH, McMillan MT, Ahrens WA, Walters AL, Thompson KJ, Kuwada TS, Martinie JB, Iannitti DA, Gersin KS, Sindram D.

Obes Surg. 2014 Jan;24(1):15-21. doi: 10.1007/s11695-013-1044-6.

PMID:
23934335
2.

Histopathologic variability between the right and left lobes of the liver in morbidly obese patients undergoing Roux-en-Y bypass.

Larson SP, Bowers SP, Palekar NA, Ward JA, Pulcini JP, Harrison SA.

Clin Gastroenterol Hepatol. 2007 Nov;5(11):1329-32. Epub 2007 Aug 16.

PMID:
17702661
3.

Evaluation of the nonalcoholic fat liver disease fibrosis score for patients undergoing bariatric surgery.

Pimentel SK, Strobel R, Gonçalves CG, Sakamoto DG, Ivano FH, Coelho JC.

Arq Gastroenterol. 2010 Apr-Jun;47(2):170-3.

4.

Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years.

Furuya CK Jr, de Oliveira CP, de Mello ES, Faintuch J, Raskovski A, Matsuda M, Vezozzo DC, Halpern A, Garrido AB Jr, Alves VA, Carrilho FJ.

J Gastroenterol Hepatol. 2007 Apr;22(4):510-4.

PMID:
17376042
5.

Effect of Roux-en-Y gastric bypass on nonalcoholic fatty liver disease evaluated through NAFLD fibrosis score: a prospective study.

Cazzo E, Jimenez LS, Pareja JC, Chaim EA.

Obes Surg. 2015 Jun;25(6):982-5. doi: 10.1007/s11695-014-1489-2.

PMID:
25381118
6.

Comparison of NAFLD fibrosis score and BARD score in predicting fibrosis in nonalcoholic fatty liver disease.

Ruffillo G, Fassio E, Alvarez E, Landeira G, Longo C, Domínguez N, Gualano G.

J Hepatol. 2011 Jan;54(1):160-3. doi: 10.1016/j.jhep.2010.06.028. Epub 2010 Aug 22.

PMID:
20934232
7.

Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.

Ong JP, Elariny H, Collantes R, Younoszai A, Chandhoke V, Reines HD, Goodman Z, Younossi ZM.

Obes Surg. 2005 Mar;15(3):310-5.

PMID:
15826462
8.

Improvement of nonalcoholic fatty liver disease after bariatric surgery in morbidly obese Chinese patients.

Tai CM, Huang CK, Hwang JC, Chiang H, Chang CY, Lee CT, Yu ML, Lin JT.

Obes Surg. 2012 Jul;22(7):1016-21. doi: 10.1007/s11695-011-0579-7.

PMID:
22161114
9.

The utility of the "NAFLD fibrosis score" in morbidly obese subjects with NAFLD.

Qureshi K, Clements RH, Abrams GA.

Obes Surg. 2008 Mar;18(3):264-70. doi: 10.1007/s11695-007-9295-8. Epub 2008 Jan 24.

PMID:
18214632
10.

Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease.

McPherson S, Stewart SF, Henderson E, Burt AD, Day CP.

Gut. 2010 Sep;59(9):1265-9. doi: 10.1136/gut.2010.216077.

PMID:
20801772
11.

Usefulness of an index score as a predictor of hepatic fibrosis in obese patients undergoing bariatric surgery.

Rodríguez RD, Pomar MD, Fernández AC, de Francisco TG, Goñi JL.

Rev Esp Enferm Dig. 2009 Aug;101(8):528-35. English, Spanish.

12.

Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease.

Weiner RA.

Dig Dis. 2010;28(1):274-9. doi: 10.1159/000282102. Epub 2010 May 7.

PMID:
20460923
13.
14.

Predictors of nonalcoholic steatohepatitis in patients undergoing bariatric surgery: when is liver biopsy indicated?

Helling TS, Helzberg JH, Nachnani JS, Gurram K.

Surg Obes Relat Dis. 2008 Sep-Oct;4(5):612-7. doi: 10.1016/j.soard.2007.11.007. Epub 2008 Jan 28.

PMID:
18226970
15.

Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients.

Bedossa P, Poitou C, Veyrie N, Bouillot JL, Basdevant A, Paradis V, Tordjman J, Clement K.

Hepatology. 2012 Nov;56(5):1751-9. doi: 10.1002/hep.25889.

PMID:
22707395
16.
17.

Complex non-invasive fibrosis models are more accurate than simple models in non-alcoholic fatty liver disease.

Adams LA, George J, Bugianesi E, Rossi E, De Boer WB, van der Poorten D, Ching HL, Bulsara M, Jeffrey GP.

J Gastroenterol Hepatol. 2011 Oct;26(10):1536-43. doi: 10.1111/j.1440-1746.2011.06774.x.

PMID:
21950746
18.

Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery.

Beymer C, Kowdley KV, Larson A, Edmonson P, Dellinger EP, Flum DR.

Arch Surg. 2003 Nov;138(11):1240-4.

PMID:
14609874
19.

Are simple noninvasive scoring systems for fibrosis reliable in patients with NAFLD and normal ALT levels?

McPherson S, Anstee QM, Henderson E, Day CP, Burt AD.

Eur J Gastroenterol Hepatol. 2013 Jun;25(6):652-8. doi: 10.1097/MEG.0b013e32835d72cf.

PMID:
23325287
20.

Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease.

Mathurin P, Hollebecque A, Arnalsteen L, Buob D, Leteurtre E, Caiazzo R, Pigeyre M, Verkindt H, Dharancy S, Louvet A, Romon M, Pattou F.

Gastroenterology. 2009 Aug;137(2):532-40. doi: 10.1053/j.gastro.2009.04.052. Epub 2009 May 4.

PMID:
19409898

Supplemental Content

Support Center